These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 15022779)

  • 1. [Ivermectin use in tropical medicine].
    Dupouy-Camet J; Yera H; Tourte-Schaefer C
    Arch Pediatr; 2003 Dec; 10 Suppl 5():545s-549s. PubMed ID: 15022779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Ivermectin and tropical dermatoses].
    Caumes E
    Bull Soc Pathol Exot; 1997; 90(1):37-8. PubMed ID: 9264749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ivermectin: pharmacology and application in dermatology.
    Dourmishev AL; Dourmishev LA; Schwartz RA
    Int J Dermatol; 2005 Dec; 44(12):981-8. PubMed ID: 16409259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Indication of Mectizan in human medicine other than onchocerciasis].
    Richard-Lenoble D
    Sante; 1998; 8(1):84-7. PubMed ID: 9592892
    [No Abstract]   [Full Text] [Related]  

  • 5. [New indications of ivermectin].
    Caumes E; Danis M
    Rev Med Interne; 2001 Apr; 22(4):379-84. PubMed ID: 11586522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Broadening the range of use cases for ivermectin - a review of the evidence.
    Kositz C; Bradley J; Hutchins H; Last A; D'Alessandro U; Marks M
    Trans R Soc Trop Med Hyg; 2022 Mar; 116(3):201-212. PubMed ID: 34323283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A Nobel Prize in Medicine 2015 for tropical countries: ivermectin, an antiparasitic drug undeniable against filariasis].
    Danis M; Richard-Lenoble D
    Med Sci (Paris); 2016 Jan; 32(1):110-5. PubMed ID: 26850616
    [No Abstract]   [Full Text] [Related]  

  • 8. Ivermectin in dermatology.
    del Giudice P; Chosidow O; Caumes E
    J Drugs Dermatol; 2003 Jan; 2(1):13-21. PubMed ID: 12852376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ivermectin].
    Develoux M
    Ann Dermatol Venereol; 2004; 131(6-7 Pt 1):561-70. PubMed ID: 15318139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ivermectin in human medicine, an overview of the current status of its clinical applications.
    González P; González FA; Ueno K
    Curr Pharm Biotechnol; 2012 May; 13(6):1103-9. PubMed ID: 22039800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Unique Case of Cutaneous Larva Migrans Acquired Within the Province of Quebec and Successfully Treated With Topical Ivermectin.
    Smilga AS; Bujold J
    J Cutan Med Surg; 2018; 22(3):347-348. PubMed ID: 29373923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of 18 children with scabies or cutaneous larva migrans using ivermectin.
    del Mar Sáez-De-Ocariz M; McKinster CD; Orozco-Covarrubias L; Tamayo-Sánchez L; Ruiz-Maldonado R
    Clin Exp Dermatol; 2002 Jun; 27(4):264-7. PubMed ID: 12139665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ivermectin: uses and impact 20 years on.
    Fox LM
    Curr Opin Infect Dis; 2006 Dec; 19(6):588-93. PubMed ID: 17075336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Autochthonous cutaneous larva migrans in Chile. A case report].
    González F CG; Galilea O NM; Pizarro C K
    Rev Chil Pediatr; 2015; 86(6):426-9. PubMed ID: 26455707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ivermectin, a potential anticancer drug derived from an antiparasitic drug.
    Tang M; Hu X; Wang Y; Yao X; Zhang W; Yu C; Cheng F; Li J; Fang Q
    Pharmacol Res; 2021 Jan; 163():105207. PubMed ID: 32971268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ivermectin: From theory to clinical application.
    Ashour DS
    Int J Antimicrob Agents; 2019 Aug; 54(2):134-142. PubMed ID: 31071469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral ivermectin for the treatment and prophylaxis of scabies in prison.
    Ribeiro Fde A; Taciro E; Guerra MR; Eckley CA
    J Dermatolog Treat; 2005 Aug; 16(3):138-41. PubMed ID: 16096178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Model-based analysis of trial data: microfilaria and worm-productivity loss after diethylcarbamazine-albendazole or ivermectin-albendazole combination therapy against Wuchereria bancrofti.
    de Kraker ME; Stolk WA; van Oortmarssen GJ; Habbema JD
    Trop Med Int Health; 2006 May; 11(5):718-28. PubMed ID: 16640625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphatic filariasis.
    Prescrire Int; 2008 Feb; 17(93):36. PubMed ID: 18383658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ivermectin: 25 years and still going strong.
    Omura S
    Int J Antimicrob Agents; 2008 Feb; 31(2):91-8. PubMed ID: 18037274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.